14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
IBP vs TMHC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Taylor Morrison Home Corporation (TMHC) captures the overall head-to-head institutional edge over Installed Building Products, Inc. (IBP) on higher Unified Composite conviction (50.7/100 HOLD vs. 41.7/100 SELL) after splitting the core matrix 7–3 (led by Valuation Multiples, Options & Positioning), while IBP wins 4–2 across the 6-pillar growth and valuation breakdown. IBP trades at $221.42 (21.3x Forward P/E, 11.9% operating margin) versus TMHC at $72.45 (11.3x Forward P/E, 11.1% operating margin).
Growth vs. Quality Trade-Off: TMHC earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. IBP 41.7/100 SELL) and 0.79β · 3% Vol risk profile, whereas IBP leads top-line expansion (+3.9% YoY revenue growth, 1.20x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IBP vs TMHC. Trailing 12-month operating profitability (IBP 11.9% vs TMHC 11.1%) and valuation multiples (IBP 21.3x vs TMHC 11.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Residential Construction value chain with $6.6B market capitalization and 11.1% operating margin.
OpEx & R&D Reinvestment11.5% of Rev ($875M)
90D Engineering Disclosures0 Published
Investor FAQ IBP vs TMHC Key Questions & Quantitative Answers
As of Nov 20, 2026, Taylor Morrison Home Corporation (TMHC) captures the overall head-to-head institutional edge over Installed Building Products, Inc. (IBP) on higher Unified Composite conviction (50.7/100 HOLD vs. 41.7/100 SELL) after splitting the core matrix 7–3 (led by Valuation Multiples, Options & Positioning), while IBP wins 4–2 across the 6-pillar growth and valuation breakdown. IBP trades at $221.42 (21.3x Forward P/E, 11.9% operating margin) versus TMHC at $72.45 (11.3x Forward P/E, 11.1% operating margin). Growth vs. Quality Trade-Off: TMHC earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. IBP 41.7/100 SELL) and 0.79β · 3% Vol risk profile, whereas IBP leads top-line expansion (+3.9% YoY revenue growth, 1.20x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
IBP leads the Growth & Scale pillar: IBP posts +3.9% YoY revenue growth and -18.2% YoY earnings growth on $2.99B TTM revenue (33.1% gross margin, 11.9% operating margin), compared with TMHC at -26.8% YoY revenue growth and -51.2% YoY earnings growth on $7.61B TTM revenue (22.6% gross margin, 11.1% operating margin). On trailing 12-month operating scale, IBP generates $2.99B in USD-normalized revenue versus $7.61B for TMHC. In operating R&D and SG&A reinvestment, IBP deploys 21.2% of Rev ($635M) (0 90-day corporate R&D disclosures) versus 11.5% of Rev ($875M) (0 disclosures) for TMHC.
TMHC screens cheaper on headline valuation multiples. IBP trades at 21.3x Forward P/E, 25.3x Trailing P/E, 1.20x PEG, and 2.1x EV/Revenue (15.7% EBITDA margin), whereas TMHC trades at 11.3x Forward P/E, 10.8x Trailing P/E, 1.41x PEG, and 1.1x EV/Revenue (9.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IBP (34.3% ROE) versus TMHC (11.1% ROE) capital efficiency.
In options market volatility and institutional positioning, IBP carries 44.5% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.33β · 64% Vol realized risk). By comparison, TMHC carries 0.2% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.79β · 3% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.